IP Cases — 2022
744 decisions across all jurisdictions
Page 20 of 25 · 744 total
Novartis AG v.Medipol Pharmaceuticals India Pvt Ltd
Novartis AG filed a suit seeking permanent injunction against Medipol Pharmaceuticals India Pvt Ltd and Metrochem Api Private Limited for infringing its patent (No. 233161) covering 'Eltrombopag Olamine', the API in Revolade. The court found that both defendants acknowledged the validity of the patent and admitted they had not manufactured or commercially sold the patented product, leading to a decree granting permanent injunction during the patent's term.
Ds Intellectual Properties Pvt. Ltd. v.Mr. Faizi Khan
This Delhi High Court order addresses a trademark infringement suit filed by Ds Intellectual Properties Pvt. Ltd. against Mr. Faizi Khan regarding the use of similar marks, specifically '0'/'ZERO' versus '00', on respective products. The court noted the dispute over consumer confusion and directed the defendant to consider modifying their mark or label design. Crucially, the defendant was ordered to cease manufacturing fresh stock using the disputed marks pending further proceedings.
Ashok Kumar Gupta & Anr. v.Neeram Garg & Ors.
In this commercial suit concerning the brand SAKRNI PLASTER, the Delhi High Court issued several procedural orders on April 7, 2022. The court granted exemptions to the Plaintiffs regarding document filing and advance notice service due to urgency. Crucially, the court allowed an application for ex-parte ad-interim injunction under Order 39 Rules 1 and 2 CPC, leading to the appointment of Local Commissioners to seize infringing products and inspect the Defendants' premises.
Shree Vari Multiplast India Pvt. Ltd. v.Nilkamal Plastics Limited
Shree Vari Multiplast India Pvt. Ltd. filed a suit against Nilkamal Plastics Limited alleging infringement of Design No.176931 related to plastic moulded chairs, seeking permanent injunction and declaration that the Cease and Desist Notice was unjustifiable. The plaintiff argued that the design was common use in the industry and liable for rectification due to lack of novelty. However, the court ultimately dismissed the suit as infructuous, noting that the registered design's protection period had expired.
Shree Vari Multiplast India Pvt. Ltd. v.Nilkamal Plastics Limited
Shree Vari Multiplast India Pvt. Ltd. filed a suit against Nilkamal Plastics Limited, seeking permanent injunction against alleged infringement of Design No.176931 related to plastic moulded chairs. The plaintiff argued that the design was common knowledge and liable for rectification or revocation. However, the court ultimately dismissed the suit as infructuous because the registration period for the design had expired.
Ab Initio Technology Llc v.Assistant Controller Of Patents And Designs
The Appellant filed an appeal challenging the rejection of its patent application (No. 6500/DELNP/2011). The court first condoned a delay of 53 days in filing the appeal, and subsequently granted further time to the Respondent to file their reply.
Boehringer Ingelheim Pharma Gmbh And Co. Kg v.Natco Pharma Limited
The judgment addresses multiple applications within a commercial suit concerning pharmaceutical patents. The court disposed of an application regarding electronic records and issued directions on several other pending matters, including contempt proceedings related to the sale of Afatinib tablets.
Shree Vari Multiplast India Pvt. Ltd. v.Nilkamal Plastics Limited
Shree Vari Multiplast India Pvt. Ltd. filed a suit against Nilkamal Plastics Limited seeking permanent injunction regarding alleged infringement of Design No.176931 related to plastic moulded chairs. The plaintiff argued that the design was common knowledge and liable for rectification, while also challenging the defendant's Cease and Desist Notice. However, the court ultimately dismissed the suit as infructuous because the registered design rights had expired.
Chugai Seiyaku Kabushiki Kaisha v.Controller Of Patents And Design
Chugai Seiyaku Kabushiki Kaisha appealed the rejection of its patent application (No. 201617023236) for a solid preparation containing Tofogliflozin in monohydrate crystal form. The Controller rejected the application, citing lack of inventive step and falling under Section 3(d) because it was merely a new use/form of a known drug without enhanced efficacy.
Macleods Pharmaceuticals Ltd v.The Controller Of Patents & Anr.
The court addressed two matters concerning the revocation of Indian Patent No. 243301, which covers the compound Linagliptin. The proceedings involved procedural steps such as treating a plaint as a petition and returning counter statements under objections.
Deepak Singh v.Bunty Raghav (Producer) and others
Deepak Singh filed a petition seeking interim relief against producers (Respondents) who were making a film based on his book, 'Janhit Mein Jaari'. The core dispute revolved around copyright infringement. While the High Court noted that the civil suit was pending before the Trial Court and emphasized the need for evidence regarding similarity between the book and the film, it ultimately directed the parties to proceed with the trial court's application under Order 39 Rule 1 and 2 of C.P.C., ensuring the existing interim relief continued until a final decision.
Rpg Enterprises Limited v.M/S Vijay Goel & Anr.
The Delhi High Court dismissed the defendants' application seeking further time to file their written statement in a trademark infringement suit. The court emphasized that despite pandemic-related considerations, the defendants were fully aware of the proceedings and failed to adhere to strict timelines. While denying the extension, the court also directed the defendants to file an affidavit detailing the quantum and sales figures of products using the disputed 'RPG' mark.
M/S Blue Heaven Cosmetics Private Limited. v.Deepak Arora & Anr.
The Delhi High Court ruled in favor of M/S Blue Heaven Cosmetics, ordering the cancellation and rectification of a conflicting trademark registered by Deepak Arora ('MARC HEAVEN'). The court found that 'MARC HEAVEN' was deceptively similar to the Petitioner's established mark 'BLUE HEAVEN,' particularly due to the appropriation of the dominant feature 'Heaven.' Citing Sections 9 and 11 of the Trade Marks Act, the judgment held that the Respondent's registration lacked distinctive character and caused public confusion.
Savelife Foundation v.Mr. Aslam Shaikh & Ors.
The Delhi High Court granted an ex parte ad-interim injunction in favor of Savelife Foundation against Mr. Aslam Shaikh and others. The court found that Defendants were fraudulently using deceptively similar trademarks ('Save LIFE' and 'Save LIFE Foundation') and associated domains to solicit funds, thereby infringing the Plaintiff's well-known trademark and committing passing off. This immediate relief aims to prevent irreparable harm while the main suit proceeds.
Indiabulls Housing Finance Ltd. v.Www.Dhanifinance.In & Anr.
The Delhi High Court ruled in favor of Indiabulls Housing Finance Ltd., granting permanent injunctions against Www.Dhanifinance.In for trademark infringement, passing off, and unfair competition. The court found that the defendant was operating a fraudulent website using deceptively similar marks ('Indiabulls', 'Dhani') and domain names to mislead consumers into believing they were dealing with Indiabulls Group. Consequently, the defendant's website operation was suspended, and damages were awarded.
Red Bull Ag v.Pepsico India Holdings Pvt Ltd & Anr
The Delhi High Court dismissed Red Bull's application for an interim injunction against Pepsico India Holdings regarding the use of the tagline 'STIMULATES MIND. ENERGIZES BODY.' by their product STING. The court found that both taglines are descriptive and laudatory in nature, meaning the plaintiff failed to establish a prima facie case at this stage. Furthermore, the balance of convenience favored the defendants given their long-standing market presence with the tagline.
Vifor (International) Ltd v.Hetero Healthcare Limited
Vifor (International) Ltd filed suit against Hetero Healthcare Limited alleging infringement of its patented drug, FERRIC CARBOXYMALTOSE. Vifor contended that Hetero was preparing to launch a generic version under the brand HETROFER, which infringed upon their exclusive patent rights for treating iron deficiency anaemia. The Delhi High Court examined the prima facie case and balance of convenience presented by the Plaintiffs.
Shivnath Rai Harnarain India Ltd. v.Mr. Rakesh Kumar And Ors
In this trademark dispute, the Delhi High Court provided a final opportunity for the Plaintiff, Shivnath Rai Harnarain India Ltd., to formally include an assignee of the trademarks 'LALMAHAL' and 'SHRILALMAHAL' in the ongoing litigation. The court noted that the assignment occurred in 2018 and granted four weeks to file the necessary application. Failure to do so will result in the suit proceeding without the new party on record.
Beardsell Limited v.Beardsell Polymers Pvt. Ltd.
The Madras High Court ruled in favor of Beardsell Limited, granting a perpetual injunction against two defendants (Beardsell Polymers Pvt. Ltd. and Beardsell Equipments Pvt. Ltd.) for passing off the company's trademark 'Beardsell'. The court found that these entities unlawfully appropriated the Plaintiff's established corporate name and were carrying on similar lines of business, risking public deception. Consequently, the injunction was granted, barring them from using or advertising the mark.
Lt Overseas North America Inc & Anr. v.Sai Krishna Foods
The Delhi High Court granted an ex-parte ad-interim injunction in favor of Lt Overseas North America Inc & Anr. against Sai Krishna Foods regarding trademark infringement. The Plaintiffs successfully demonstrated that their 'ROYAL' mark is well-known, enjoys significant goodwill, and the Defendant was using a similar mark to cause consumer confusion. Consequently, the court restrained the defendant from selling infringing products and ordered a Local Commissioner to search and seize the counterfeit goods.
Shabeer Ahmad Bhat v.Sushil Kumar Pathak
The Delhi High Court allowed an application filed by the petitioner seeking to correct a clerical error in a prior order. The correction involved changing the name of the entity receiving trademark assignments from 'Globiotech International' to 'M/s Glow Biotech Ltd', as stipulated in the underlying Memorandum of Understanding (MoU). This minor but crucial rectification ensures the court record accurately reflects the parties' agreement regarding the assignment of trademarks.
Malabar Cements Limitd v.Drawing And Disbursing Officer, The Office of the Trademarks Registry; The Registrar of Trademarks
The Madras High Court allowed Malabar Cements Limited's Writ Petition, setting aside an earlier rejection order from the Trademarks Registry. The court ruled that a Notice of Opposition filed against Trademark Application No 427808 fell within the prescribed window for filing opposition, based on a public notice issued by the Controller General of Patents, Designs & Trademarks. Consequently, the respondents agreed to accept and record the opposition upon re-submission within three weeks.
Usha International Limited v.Registrar Of Trademarks And Anr.
Usha International Limited filed a petition seeking the removal/cancellation of the mark 'WSHA' from the Trade Marks Register, arguing that it is deceptively similar to their long-standing mark 'USHA'. The Delhi High Court accepted the petition and issued notice to the respondents. The matter was subsequently listed for further arguments on April 4, 2022.
Novartis Ag v.Msn Laboratories Pvt. Ltd
The case involves Novartis AG seeking a permanent injunction against MSN Laboratories Pvt. Ltd. for infringing its patent related to Eltrombopag Olamine, the active ingredient in its drug Revolade.
Chia Tai Tianqing Pharmaceutical Group Co. Ltd v.The Controller of Patents and Designs
The suit was filed by Chia Tai Tianqing Pharmaceutical Group challenging an impugned order from the Assistant Controller of Patents & Designs. The rejection was based on Section 2(1)(ja), Section 3(d), and Section 10 of the Patents Act, 1970. The plaintiff argued that the objections under Section 10 were never raised during examination and that deleted claims were improperly used for rejection.
Tata Consumer Products Limited v.M/S Varahi Limited & Anr.
The Delhi High Court addressed several interlocutory applications in the trademark infringement suit filed by Tata Consumer Products Limited against M/S Varahi Limited. The court allowed defendants to file their original notarized affidavits and permitted the plaintiff to place numerous additional documents on record, including sales turnover details and evidence of prior meetings. While the core dispute involves the use of the 'HIMALAYAN' mark for mineral water, the current order focuses on procedural steps necessary to build a comprehensive case before trial.
Ischemix Llc v.The Controller Of Patents
Ischemix Llc appealed the rejection of its Indian Patent Application No.4380/DELNP/2013 by the Controller of Patents, which was based on Section 3(d) of the Patents Act, 1970. The appellant challenged the basis and citation of the prior art documents used against them.
Attachmate Corporation v.DCIT, International Taxation, Circle-1(1)(1)
The assessee, a US company dealing in software products, challenged the Assessing Officer's order which treated income received from Indian distributors as 'Royalty' chargeable under Article 12 of the India-USA DTAA. The Tribunal held that since no right in copyright was being transferred, the consideration could not be taxed as royalty.
Agriboard International Llc v.Deputy Controller Of Patents And Designs
Agriboard International LLC appealed the Deputy Controller's order refusing its patent application for 'Efficient Method and Apparatus for Producing Compressed Structural Fiberboard' on grounds of lack of inventive step. The petitioner argued that the refusal was cryptic and lacked proper reasoning regarding the differences between the subject invention and the cited prior art (D1).
Pfizer Inc & Ors v.Azista Industries Private Limited & Ors
Pfizer Inc and others filed a suit seeking permanent injunction, damages, and rendition of accounts against Azista Industries Private Limited and others for infringing their patented drug 'Palbociclib'. The court found that the Plaintiffs had made out a prima facie case for an ad-interim ex parte injunction.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.